Filing metadata

Accession number
0001209191-21-031905
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
May 11, 2021
Reporting period
May 10, 2021
Description
Insider transaction

Explore SEC Filings Hub